Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Balasch

Showing results (161-170 of 209) with videos related to

Pageof 21
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|August 10, 2000
Circulating levels of nitric oxide in successful and unsuccessful implantation after in vitro fertilization and embryo transfer. Relationship to estradiol and progesteroneF Fábregues, J Balasch, D Manau, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 1, 1996
Further data favoring the hypothesis of the uterine first-pass effect of vaginally administered micronized progesteroneJ Balasch, F Fábregues, J Ordi, et al.
Human Reproduction (Oxford, England)|November 7, 1998
Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndromeF Fábregues, J Balasch, D Manau, et al.
Human Reproduction (Oxford, England)|January 14, 1999
Integrin expression in normal and out-of-phase endometriaM Creus, J Balasch, J Ordi, et al.
Autoimmunity|January 1, 1991
The 'primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patientsJ Font, A López-Soto, R Cervera, et al.
The Journal of Small Animal Practice|April 27, 2016
Adverse urinary effects of allopurinol in dogs with leishmaniasisM Torres, J Pastor, X Roura, et al.
Human Reproduction (Oxford, England)|November 1, 1996
Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilizationJ Balasch, F Fábregues, M Creus, et al.
Journal of Assisted Reproduction and Genetics|April 8, 2000
Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications for implantation potentialJ Balasch, F Fábregues, M Creus, et al.
Human Reproduction (Oxford, England)|July 28, 2001
Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSHJ Balasch, E Vidal, J Peñarrubia, et al.
Journal of Assisted Reproduction and Genetics|July 24, 2001
The effect of exogenous luteinizing hormone (LH) on oocyte viability: evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproductionJ Balasch, M Creus, F Fábregues, et al.
Pageof 21

Showing results (161-170 of 209) with videos related to

Sort By:
Pageof 21
Acta Obstetricia Et Gynecologica Scandinavica|August 10, 2000
Circulating levels of nitric oxide in successful and unsuccessful implantation after in vitro fertilization and embryo transfer. Relationship to estradiol and progesteroneF Fábregues, J Balasch, D Manau, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 1, 1996
Further data favoring the hypothesis of the uterine first-pass effect of vaginally administered micronized progesteroneJ Balasch, F Fábregues, J Ordi, et al.
Human Reproduction (Oxford, England)|November 7, 1998
Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndromeF Fábregues, J Balasch, D Manau, et al.
Human Reproduction (Oxford, England)|January 14, 1999
Integrin expression in normal and out-of-phase endometriaM Creus, J Balasch, J Ordi, et al.
Autoimmunity|January 1, 1991
The 'primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patientsJ Font, A López-Soto, R Cervera, et al.
The Journal of Small Animal Practice|April 27, 2016
Adverse urinary effects of allopurinol in dogs with leishmaniasisM Torres, J Pastor, X Roura, et al.
Human Reproduction (Oxford, England)|November 1, 1996
Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilizationJ Balasch, F Fábregues, M Creus, et al.
Journal of Assisted Reproduction and Genetics|April 8, 2000
Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications for implantation potentialJ Balasch, F Fábregues, M Creus, et al.
Human Reproduction (Oxford, England)|July 28, 2001
Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSHJ Balasch, E Vidal, J Peñarrubia, et al.
Journal of Assisted Reproduction and Genetics|July 24, 2001
The effect of exogenous luteinizing hormone (LH) on oocyte viability: evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproductionJ Balasch, M Creus, F Fábregues, et al.
Pageof 21